Dr Reddy

Markets close day's session on buoyant note: Sensex up 622 points, Nifty above 9,050-mark; HDFC top gainer, surges over 5%

The Sensex settled 622.44 points or 2.06 percent higher at 30,818.61, while the NSE Nifty rose 187.45 points, or 2.11 percent, to end at 9,066.55

Sensex pares losses, rises over 100 points ahead of US Fed policy meet

The market shrugged off early losses despite global weakness. IT stocks led the recovery momentum, as Sensex reclaimed the 33,000-level

SEBI asks for trading data on companies after prescient messages on company earnings leak on WhatsApp

Ajay Tyagi, chairman of SEBI, told Reuters last week that the regulator will investigate the matter.

Sensex rebounds 68 points as pharma, FMCG, banking shares rise

Buying by participants in the last 30 minutes of trading helped the gauge bounce back to close 68.22 points, or 0.23 percent, higher at 29,448.95.

Delhi polls, earnings weigh on as markets head for 7th day of decline

The BSE Sensex and Nifty continued their downward trend on Monday as the Delhi Election outcome and earnings weighed on sentiments.

Sensex closes above 28,000 for 2nd straight day, rises over 140 points

Extending its rising streak for the third straight session, the benchmark BSE Sensex surged over 140 points to close at 28,262.01, led by gains in IT major Wipro and financial stocks on encouraging earnings.

Sensex, Nifty hit new closing highs on Eurozone stimulus hopes, US data

In five days, Sensex has gained about 246 points.<br />

Pharma sector registers single digit growth in 2013; regulators increase scrutiny

The Indian pharma sector, estimated to be around Rs 1.5 lakh crore, recorded single digit growth for the first time in several years on account of deeper price cuts under pricing policy and selective boycott of companies by the retailers.

Dr Reddy's sued for 'infringement' of thyroid injection patent

US-based drug maker AbbVie Inc, the spun-off entity of Abbott, has dragged Dr Reddy's Lab to court for allegedly infringing the former's patented drug Zemplar on six counts concerning three patents.<br /><br />

Soon, one out of 5 diabetic patients will be Indian: Dr Reddy

Observing that the country's healthcare sector faces many challenges, a top Indian corporate leader has emphasised on the need of greater co-operation between India and the US in this area.